Study of the inhibitory effects of PPAR ligands on the TGF-beta-induced liver fibrosis.
碩士 === 臺北醫學大學 === 醫學技術學系 === 94 === Fibrosis is the liver’s scarring response to injury that occurs in most chronic inflammatory liver diseases. The ultimate result of chronic injury is the accumulation of extracellular matrix (ECM). Transforming growth factor-beta(TGF-beta), the potent profibrogeni...
Main Authors: | Ching-Ju Cheng, 鄭靜茹 |
---|---|
Other Authors: | Yu-Chih Liang |
Format: | Others |
Language: | zh-TW |
Published: |
2006
|
Online Access: | http://ndltd.ncl.edu.tw/handle/80078276465336048997 |
Similar Items
-
Using retinoic acid derivative molecules to antagonize the TGF-beta induced early liver fibrosis
by: Kun-Lin Yang, et al.
Published: (2008) -
PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.
by: Ajit A Kulkarni, et al.
Published: (2011-01-01) -
The inhibitory capabilities of Silibinin and Glycyrrhizin on hepatitis C virus replication and TGF-b1-induced liver fibrosis
by: Yen-Chen, et al.
Published: (2010) -
Inhibitory effect of tetrahydrocurcumin on dimethylnitrosamine-induced liver fibrosis in rats
by: Monthana Weerawatanakorn, et al.
Published: (2014-03-01) -
Effects of PPARγ ligands on TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells
by: Dagher Hayat, et al.
Published: (2010-02-01)